Screening for Hepatocellular Carcinoma and Cholangiocarcinoma: Can Biomarkers Replace Imaging?
- 29 May 2015
- journal article
- research article
- Published by Springer Nature in Current Hepatology Reports
- Vol. 14 (2) , 128-138
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and ManagementGastroenterology, 2013
- Biliary Tract Cancers in Olmsted County, Minnesota, 1976–2008American Journal of Gastroenterology, 2012
- Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysisBMC Cancer, 2012
- Cancer surveillance in patients with primary sclerosing cholangitisHepatology, 2011
- Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract CancerJournal of Clinical and Experimental Hepatology, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Comparison of KRAS Mutation Analysis and FISH for Detecting Pancreatobiliary Tract Cancer in Cytology Specimens Collected During Endoscopic Retrograde CholangiopancreatographyThe Journal of Molecular Diagnostics, 2010
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular CarcinomaGastroenterology, 2009
- The Utility of Lens Culinaris Agglutinin-Reactive α-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: Evaluation in a United States Referral PopulationClinical Gastroenterology and Hepatology, 2007